December 8, 1999 |
Robert A. Swanson, co-founder and pioneering leader of Genentech Inc., which as one of the first and most successful companies in the burgeoning biotechnology industry developed human insulin and human growth hormone, has died. Swanson, a financial wizard with a chemistry degree who left Genentech in 1996, died Monday of brain cancer at his home in Hillsborough, a San Francisco suburb. He was 52. Most recently, Swanson had been chairman of the board of Tularik Inc.
February 17, 1985
Genentech Inc., a major bioengineering firm, on Thursday named G. Kirk Raab president and chief operating officer. The latter is a new position. Raab, 49, has a wide background with pharmaceutical companies, most recently at Abbott Laboratories, where he was president and chief operating officer. The move signals the company's shift from pure bioengineering research to marketing and manufacturing of products derived from so-called recombinant DNA technology. As president, Raab succeeds Robert A.
December 13, 1996 |
San Francisco-based First Nationwide Holdings Inc., the parent company of First Nationwide Bank, received approval from the Office of Thrift Supervision for its purchase of Los Angeles-based CalFed Bancorp Inc. First Nationwide announced plans in July to buy CalFed for $1.2 billion in cash. . . . South San Francisco-based Genentech Inc. said Robert A. Swanson, founder of the biotechnology company, will retire as chairman at the end of the month. . . .